RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Sep 15, 2017 - 4:49:58 AM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
Huge 'biobank' for research into major diseases to be set up by Qatar and Imperial College London

Oct 28, 2010 - 4:00:00 AM
Professor Paul Elliott, Head of the Department of Epidemiology and Biostatistics at Imperial College London, said: This is a fantastic opportunity to set up a world-leading project, following up the health of a population over many years, and really try and understand the causes of disease, both genetic and environmental.

 
[RxPG] A biobank of samples and clinical measurements from tens of thousands of people is to be established in Qatar to help scientists understand the causes of major diseases and develop new treatments, it is announced today.

The Qatar Biobank is being established by Qatar Foundation for Education, Science, and Community Development (QF) and Qatar's Supreme Council of Health, with the assistance of experts from Imperial College London. The project was announced at the Royal Society today in the presence of Her Highness Sheikha Mozah bint Nasser Al-Missned, during the Qatari state visit to the UK.

The biobank will collect a wealth of medical data from up to 100,000 volunteers and store samples of their blood and urine in a high-tech storage facility over many years. This will allow scientists to look at diseases already present in the population as well as following up the participants to see who develops disease in the future. Researchers will compare data, including genetic information and data on environmental exposures and lifestyles, from participants who develop illnesses with data from those who remain healthy. In this way, they aim to identify early markers that can indicate when someone is likely to develop a particular disease, so that people will be able to receive early treatment or take measures to prevent a disease developing.

The Qatar Biobank will be the first very large population-based study involving the collection of biological samples in an Arabic country. It will provide scientists with an invaluable resource for improving the prevention, diagnosis and treatment of a wide range of chronic diseases, such as diabetes and heart disease, which are placing increasing demands on Qatar's free public health service.

The initiative builds on other large national and international biobanking projects such as the UK Biobank, set up in 2006, which is the most advanced project of its type in the world.

Public health experts from Imperial College London are playing a crucial role in the design and implementation of the project.

Professor Elio Riboli, Director of the School of Public Health at Imperial College London, said: At the very beginning of the study, healthy participants will be examined using top-level technology, such as MRI scans, so that later we can pick out aspects of the imaging data that may look today normal but might actually be predictive of diseases. The results will be invaluable not only for the Qatar population but for medical science in general.

Qatar is an extremely interesting population from a medical point of view. It's a population in rapid transition towards more Western lifestyles. Qatar is home to residents from different regions of the world, which means we can look at disease risk factors in multiethnic populations in detail and on a very large scale.

Professor Paul Elliott, Head of the Department of Epidemiology and Biostatistics at Imperial College London, said: This is a fantastic opportunity to set up a world-leading project, following up the health of a population over many years, and really try and understand the causes of disease, both genetic and environmental.






Advertise in this space for $10 per month. Contact us today.


Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

Online ACLS Certification

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)